Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial

James D. Chalmers, Remco S. Djamin, Marjolijn Schouten, Holly R. Keir, Brandon Tan, Joachim G.J.V. Aerts, Jeffrey T-J. Huang, Menno van der Eerden

Source: ERJ Open Res, 4 (4) 00136-2018; 10.1183/23120541.00136-2018
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
James D. Chalmers, Remco S. Djamin, Marjolijn Schouten, Holly R. Keir, Brandon Tan, Joachim G.J.V. Aerts, Jeffrey T-J. Huang, Menno van der Eerden. Circulating desmosine as a biomarker of azithromycin treatment response: a post hoc analysis of the COLUMBUS randomised controlled trial. ERJ Open Res, 4 (4) 00136-2018; 10.1183/23120541.00136-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: